Jazz Pharmaceuticals plc — Director's Dealing 2022

Dec 22, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2022-12-21

Reporting Person: GALA RENEE D (EVP & Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-21	Ordinary Shares	S	2635	$160.0	Disposed	32558	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2: Includes 147 annd 51 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2022 and November 30, 2022, respectively.